Literature DB >> 34151722

Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis.

Mohammad A Uddin1, Mohammad S Akhter1, Khadeja-Tul Kubra1, Nektarios Barabutis1.   

Abstract

Endothelial barrier dysfunction (EBD) is the hallmark of Acute Respiratory Distress Syndrome (ARDS), a potentially lethal respiratory disorder associated with the COVID-19 - related deaths. Herein, we employed a cecal ligation and puncture (CLP) murine model of sepsis, to evaluate the effects of sepsis-induced EBD in the expression of the never in mitosis A (NIMA)-related kinases (NEKs). Members of that family of kinases regulate the activity and expression of the tumor suppressor P53, previously shown to modulate the actin cytoskeleton remodeling. Our results introduce the induction of NEK2, NEK3, NEK4, NEK7, and NEK9 in a CLP model of sepsis. Hence, we suggest that NEKs are involved in inflammatory processes and are holding the potential to serve as novel therapeutic targets for pathologies related to EBD, including ARDS and sepsis. Further studies will delineate the underlying molecular events and their interrelations with P53.

Entities:  

Keywords:  ARDS; Inflammation; endothelium; p53; vasculature

Mesh:

Substances:

Year:  2021        PMID: 34151722      PMCID: PMC8794518          DOI: 10.1080/21688370.2021.1929787

Source DB:  PubMed          Journal:  Tissue Barriers        ISSN: 2168-8362


  43 in total

1.  Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function.

Authors:  Leslie A Mitchell; Christian E Overgaard; Christina Ward; Susan S Margulies; Michael Koval
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

Review 2.  Regulation of pulmonary endothelial barrier function by kinases.

Authors:  Nektarios Barabutis; Alexander Verin; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

3.  GHRH antagonists support lung endothelial barrier function.

Authors:  Mohammad A Uddin; Mohammad S Akhter; Sitanshu S Singh; Khadeja-Tul Kubra; Andrew V Schally; Seetharama Jois; Nektarios Barabutis
Journal:  Tissue Barriers       Date:  2019-10-03

4.  Aurora B kinase phosphorylates and instigates degradation of p53.

Authors:  Chris P Gully; Guermarie Velazquez-Torres; Ji-Hyun Shin; Enrique Fuentes-Mattei; Edward Wang; Colin Carlock; Jian Chen; Daniel Rothenberg; Henry P Adams; Hyun Ho Choi; Sergei Guma; Liem Phan; Ping-Chieh Chou; Chun-Hui Su; Fanmao Zhang; Jiun-Sheng Chen; Tsung-Ying Yang; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-18       Impact factor: 11.205

5.  VHL regulates NEK1 via both HIF-2α pathway and ubiquitin-proteasome pathway in renal cancer cell.

Authors:  Guang Chen; Jun Zhou; Jie Chen; Jin Zhu; Shuang-Chun Liu; Xiao-Fei Ding; Qiang Zhang
Journal:  Biochem Biophys Res Commun       Date:  2019-01-08       Impact factor: 3.575

6.  Delayed Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Inhibition by Trametinib Attenuates Systemic Inflammatory Responses and Multiple Organ Injury in Murine Sepsis.

Authors:  Joshua A Smith; Philip R Mayeux; Rick G Schnellmann
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

7.  Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition.

Authors:  Nektarios Barabutis; Christiana Dimitropoulou; Betsy Gregory; John D Catravas
Journal:  J Cell Mol Med       Date:  2018-01-24       Impact factor: 5.310

8.  Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome.

Authors:  Humayun Sharif; Li Wang; Wei Li Wang; Venkat Giri Magupalli; Liudmila Andreeva; Qi Qiao; Arthur V Hauenstein; Zhaolong Wu; Gabriel Núñez; Youdong Mao; Hao Wu
Journal:  Nature       Date:  2019-06-12       Impact factor: 49.962

9.  P53 in acute respiratory distress syndrome.

Authors:  Nektarios Barabutis
Journal:  Cell Mol Life Sci       Date:  2020-09-04       Impact factor: 9.261

10.  EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7.

Authors:  Laura O'Regan; Giancarlo Barone; Rozita Adib; Chang Gok Woo; Hui Jeong Jeong; Emily L Richardson; Mark W Richards; Patricia A J Muller; Spencer J Collis; Dean A Fennell; Jene Choi; Richard Bayliss; Andrew M Fry
Journal:  J Cell Sci       Date:  2020-05-11       Impact factor: 5.285

View more
  4 in total

1.  P53 mediates the protective effects of metformin in inflamed lung endothelial cells.

Authors:  Khadeja-Tul Kubra; Mohammad A Uddin; Mohammad S Akhter; Antoinette J Leo; Agnieszka Siejka; Nektarios Barabutis
Journal:  Int Immunopharmacol       Date:  2021-11-15       Impact factor: 4.932

2.  Unfolded protein response in endothelial injury.

Authors:  Nektarios Barabutis
Journal:  Cell Cycle       Date:  2022-05-26       Impact factor: 5.173

3.  Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption.

Authors:  Mohammad S Akhter; Khadeja-Tul Kubra; Nektarios Barabutis
Journal:  Endocrine       Date:  2022-10-20       Impact factor: 3.925

4.  Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection Status.

Authors:  Eleni Stamoula; Eleana Sarantidi; Vasilis Dimakopoulos; Alexandra Ainatzoglou; Ioannis Dardalas; Georgios Papazisis; Konstantina Kontopoulou; Athanasios K Anagnostopoulos
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.